Mammogen Raises up to $30 Million Series A Led by Major U.S. Public Retirement System to Fund Breast Cancer Diagnostic Trial
Mammogen, a Newport Beach-based company, announced the institutional equity round on June 3, 2026. The funds will support its clinical program and commercialization of genTRU-breast.
ncbi.nlm.nih.govMammogen announced an up to $30 million institutional Series A equity financing on June 3, 2026. S. public retirement system. The financing will support Mammogen's pivotal prospective clinical program and commercialization expansion.
Mammogen is a female-led predictive health company developing RNA-powered molecular diagnostics for women's health. Mammogen is headquartered in Newport Beach, California. The company was founded within the broader IV BioHoldings (IVBH) ecosystem, an innovation platform focused on advancing scalable early detection technologies across multiple disease areas.
Mammogen's lead product candidate is genTRU-breast™, a blood-based molecular assay designed to support earlier breast cancer detection. The test is particularly intended for women with dense breast tissue. Benzinga reported that the Series A positions Mammogen among the most capitalized emerging companies in women's health diagnostics.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Story details
Related Stories
cordcuttersnews.comAmazon Edges Walmart for No. 1 on 2026 Fortune 500 With $717B vs $713B Revenue
Amazon displaced Walmart to claim the top spot on the annual ranking of U.S. companies by revenue. The list was released June 3, 2026.
The IndependentMelia to Close 15 Hotels in Cuba
Melia will cease operations at 15 of its 34 hotels on the island after new U.S. sanctions targeted its local partner. The move adds to recent pullbacks by other foreign chains and follows a sharp drop in tourist arrivals.
fortune.comCanada Seeks 16-Year Renewal of USMCA Ahead of July Review
Canada has formally recommended extending the United States-Mexico-Canada Agreement for another 16 years. The proposal arrives as the pact faces its scheduled July review and amid recent U.S. trade comments.